# FDA 483 - Aetna Felt Corporation - May 13, 2021

Source: https://www.globalkeysolutions.net/records/483/aetna-felt-corporation/5e9d9720-d1b0-401f-9db1-7ad74ccbc266

> FDA 483 for Aetna Felt Corporation on May 13, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aetna Felt Corporation
- Inspection Date: 2021-05-13
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Aetna Felt Corporation, a human drug packager in Allentown, PA, revealed significant deficiencies in their manufacturing and control procedures. The firm lacked written procedures for production controls, failed to conduct annual product reviews, and did not properly qualify or maintain equipment. Additionally, employees lacked adequate GMP training, and labeling controls were insufficient, indicating a broad failure to adhere to current Good Manufacturing Practices.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/rachael-oyewole/bc642edb-4124-4cd1-b979-0d752ead1bfd)
- [Investigator](https://www.globalkeysolutions.net/people/craig-d-zagata/1e9614e4-4efe-4d11-8b85-9fd43b64d40c)

Company: https://www.globalkeysolutions.net/companies/aetna-felt-corporation/68fa179a-f273-4e80-9ec9-cd79cbd1c8f7

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8